At a glance
- Originator Sankyo
- Class Antidepressants; Pyrimidines; Small molecules
- Mechanism of Action Monoamine oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 07 Jan 1997 No-Development-Reported for Depression in Japan (Unknown route)